Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 849 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Prospective Blood Draw Clear all

Conditions: Rheumatoid Arthritis
Interventions: Vectra MBDA Test; Genetic
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 11
States / cities: Annapolis, Maryland • Baltimore, Maryland • Catonsville, Maryland + 7 more

Conditions: Macular Degeneration
Interventions: Rituximab; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 41 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Acute Spinal Cord Injury, Spinal Cord Injuries
Interventions: Measures of spasticity, connectivity and analysis of single nucleotide polymorphisms and biomarkers of inflammation, Analysis of biomarkers; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Decompensated Heart Failure
Interventions: Loop diuretics (furosemide, torsemide, bumetanide), Ultrafiltration; Drug · Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Coronavirus Disease 2019 (COVID-19), SARS-CoV-2
Interventions: Biological sample collection, Data Collection: Clinical Care Assessments; Procedure
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 1,227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 17
States / cities: Tucson, Arizona • Los Angeles, California • San Francisco, California + 14 more

Conditions: Candidemia
Interventions: Not listed
Lead sponsor: T2 Biosystems; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 5
States / cities: Birmingham, Alabama • San Francisco, California • Lexington, Kentucky + 2 more

Conditions: Pain
Interventions: Proximal Intercostal Block, Paravertebral Block; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pancreatitis
Interventions: Data Management and Monitoring; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bacteremia
Interventions: Not listed
Lead sponsor: T2 Biosystems; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Family History of Pancreas Cancer
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2040
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Anemia of End Stage Renal Disease
Interventions: Specimen collection; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 3
States / cities: Louisville, Kentucky • Springfield, Massachusetts • Durham, North Carolina

Conditions: Bronchopulmonary Dysplasia
Interventions: MagniXene, hyperpolarized 129Xe MRI; Combination Product
Lead sponsor: Xemed LLC; Industry
Eligibility: Up to 1 Year
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Septic Shock, Endotoxemia
Interventions: Toraymyxin PMX 20R Extracorporeal Hemoperfusion Cartridge; Device
Lead sponsor: Spectral Diagnostics (US) Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 20
States / cities: Birmingham, Alabama • Little Rock, Arkansas • San Francisco, California + 16 more

Conditions: Urea Cycle Disorder
Interventions: Diagnostic Ultrasound; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 5 Years to 60 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Graft Versus Host Disease
Interventions: GLASSIA, methylprednisolone or equivalent steroid, Albumin; Biological · Drug
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Aortic Valve Disease
Interventions: Blood draw; Other
Lead sponsor: Bassett Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Cooperstown, New York

Conditions: Hypertension, Pulmonary
Interventions: Blood Sample; Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 907 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 16
States / cities: Los Angeles, California • Aurora, Colorado • Jacksonville, Florida + 12 more

Conditions: Hemophilia a, Hemophilia B
Interventions: SerpinPC; Drug
Lead sponsor: ApcinteX Ltd; Industry
Eligibility: 12 Years to 65 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: Aurora, Colorado • Tampa, Florida • Indianapolis, Indiana + 7 more

Conditions: Immunologic Deficiency Syndrome
Interventions: Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™; Drug
Lead sponsor: Green Cross Corporation; Industry
Eligibility: 2 Years to 70 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Birmingham, Alabama • North Palm Beach, Florida • Chicago, Illinois + 5 more

Conditions: Huntington Disease, Huntington's Dementia, Huntington Disease, Late Onset, Huntington; Dementia (Etiology)
Interventions: Biospecimen Collection; Other
Lead sponsor: Sanguine Biosciences; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 5 participants
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Woburn, Massachusetts

Conditions: Primary Graft Failure
Interventions: FLT imaging and TK1 blood measurements; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 4 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 4
States / cities: Atlanta, Georgia • Ann Arbor, Michigan • Cleveland, Ohio + 1 more

Conditions: Hypertension
Interventions: Optical Blood Pressure Monitoring Device (Aktiia G1); Device
Lead sponsor: Nucor; Industry
Eligibility: 25 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Hypertension
Interventions: Olmesartan medoxomil, Olmesartan medoxomil/hydrochlorothiazide; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 65 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 29
States / cities: Birmingham, Alabama • Mesa, Arizona • Long Beach, California + 26 more

Conditions: Aortic Valve Stenosis
Interventions: Echocardiography, Computed tomography, Magnetic resonance imaging, Blood biomarkers, Stress echocardiography; Other
Lead sponsor: Laval University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2024
U.S. locations: 2
States / cities: Rochester, Minnesota • Pittsburgh, Pennsylvania

Search by objective public record fields.

Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Treatment -Resistant Neovascular Age-Related Macular Degeneration

Spasticity and Functional Recovery After SCI

Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics

Immunophenotyping Assessment in a COVID-19 Cohort

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)

Comparison of US-Guided Paravertebral and Proximal Intercostal Nerve Blocks

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)

Prospective Familial Registry for Pancreas Research

Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease

129Xe MRI in Pediatric Population With BPD

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

Chronic Liver Disease in Urea Cycle Disorders

A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD

Podocan and Wnt Pathway in the Development of Aortopathy in Bicuspid Valve Disease

A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)